By: Rod Tucker.
Tucker R. Community pharmacy training in dermatology and patient views on pharmacy management of skin conditions: a pilot study. SelfCare 2020;11(1)9-24.
By: Rod Tucker.
By: Andrea Stippler, Niels Eckstein, Elmar Kroth
Stippler A, Eckstein N, Kroth E. To switch or not to switch – German physicians´ views on proposed new OTC medicines. SelfCare 2019;10(1)11-23.
by Ahmed S, Rutter P M
Ahmed S, Rutter P M. UK Community Pharmacists Experiences on Over-the-Counter Tamsulosin. SelfCare 2011;2(6):152-159
In the UK, government policy toward self-care now supports the management of some long-term conditions. In 2004, simvastatin was switched to P access for people who have a moderate risk of coronary heart disease. This deregulation met with opposition from pharmacists due to concern over patient management and the increased workload burden envisaged around training and record keeping. In 2010, tamsulosin was reclassified for the treatment of urinary symptoms of benign prostatic hyperplasia (BPH); the first medicine since simvastatin to be marketed for a non self-limiting condition. This study aimed to explore community pharmacist’s early experiences with the supply of non-prescription tamsulosin.
by Bhogal S, Rutter P
Bhogal S, Rutter P. Decision making by community pharmacists when making an over-the-counter diagnosis: a pilot study – Poster. SelfCare 2013;4(1):20. Poster1
The aim of this section is to encourage the publication of student/junior faculty research projects, offering an opportunity for young and more seasoned junior researchers to publish their research in this form. Poster submissions are subject to an independent review process.